Adaptive Biotechnologies Corp — Director's Dealing 2025

Mar 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2025-03-13

Reporting Person: GRIFFIN MICHELLE RENEE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-13	Common Stock	S	36291	$7.19	Disposed	15394	Direct

Footnotes

F1: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.15 to $7.25, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.